Harrow Stock Insiders

HROW -  USA Stock  

USD 9.74  0.01  0.10%

Harrow Health employes about 125 people. The company is managed by 9 executives with total tenure of roughly 51 years, averaging almost 5.0 years of service per executive having 13.89 employees per reported executive. Recap of Harrow Health management performance can provide insight into the venture performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Harrow Health future performance.
Please check Risk vs Return Analysis.

Harrow Insiders 

  Mark Baum  CEO
CEO, Director
  Robert Kammer  Chairman
Independent Chairman of the Board
  John Saharek  President
President of ImprimisRx

Harrow Health Return on Sales


Harrow Health Management Team Effectiveness

Harrow Health has return on total asset (ROA) of 5.2 % which means that it generated profit of $5.2 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 45.32 %, meaning that it created $45.32 on every $100 dollars invested by stockholders. Harrow Health management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Return on Average Assets is likely to drop to -0.07 in 2021. Return on Average Equity is likely to drop to -0.17 in 2021. Harrow Health Total Assets are fairly stable at the moment as compared to the past year. Harrow Health reported Total Assets of 57.47 Million in 2020. Current Assets is likely to climb to about 43.3 M in 2021, whereas Asset Turnover is likely to drop 0.85 in 2021.

Harrow Health Quarterly Total Assets

106.97 MillionShare
Weighted Average Shares is likely to drop to about 20.9 M in 2021. Weighted Average Shares Diluted is likely to drop to about 21.1 M in 2021

Harrow Health Workforce Comparison

Harrow Health is one of the top stocks in number of employees category among related companies. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 244. Harrow Health totals roughly 125 in number of employees claiming about 51% of equities under Drug Manufacturers—Specialty & Generic industry.

Harrow Health Profit Margins

The company has Profit Margin (PM) of 18.6 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 8.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.08.

Harrow Health Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harrow Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harrow Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Harrow Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Harrow Health Benchmark Summation

The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Highest value over a specified period line plots max value of Harrow Health price series. View also all equity analysis or get more info about highest value over a specified period math operators indicator.

Harrow Health Notable Stakeholders

A Harrow Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Harrow Health often face trade-offs trying to please all of them. Harrow Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Harrow Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark Baum - CEO, DirectorProfile
Robert Kammer - Independent Chairman of the BoardProfile
John Saharek - President of ImprimisRxProfile
Andrew Boll - CFO, SecretaryProfile
Anthony Principi - Independent DirectorProfile
Richard Lindstrom - DirectorProfile
Stephen Austin - Independent DirectorProfile
Larry Dillaha - Chief Medical OfficerProfile
Dennis Saadeh - Chief of Formulation StrategyProfile

About Harrow Health Management Performance

The success or failure of an entity such as Harrow Health often depends on how effective the management is. Harrow Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Harrow management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Harrow management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please read more on our stock advisor page.
Last ReportedProjected for 2021
Return on Average Assets(0.06) (0.07) 
Return on Average Equity(0.16) (0.17) 
Return on Invested Capital(0.02) (0.0205) 
Return on Sales(0.023) (0.0248) 
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. Harrow Health, Inc. was founded in 1998 and is headquartered in San Diego, California. Harrow Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 125 people.
The data published in Harrow Health's official financial statements usually reflect Harrow Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Harrow Health. For example, before you start analyzing numbers published by Harrow accountants, it's critical to develop an understanding of what Harrow Health's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Harrow Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Harrow Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Harrow Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Harrow Health. Please utilize our Beneish M Score to check the likelihood of Harrow Health's management to manipulate its earnings.

Harrow Health Workforce Analysis

Traditionally, organizations such as Harrow Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Harrow Health within its industry.

Harrow Health Manpower Efficiency

Return on Harrow Health Manpower

Revenue Per Employee420 K
Revenue Per Executive5.8 M
Net Income Per Employee78.2 K
Net Income Per Executive1.1 M
Working Capital Per Employee49.6 K
Working Capital Per Executive689.4 K
Please check Risk vs Return Analysis. Note that the Harrow Health information on this page should be used as a complementary analysis to other Harrow Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Harrow Stock analysis

When running Harrow Health price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
CEO Directory
Screen CEOs from public companies around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
The market value of Harrow Health is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Harrow Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.